Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

MARK A GOLDSMITH Insider Profile

11 Followers

MARK A GOLDSMITH, President & CEO, Director at Revolution Medicines, holds 970.25K shares in Revolution Medicines (Ticker: RVMD), holds 89.86K shares in Constellation Pharmaceuticals (Ticker: CNST).

MARK A GOLDSMITH's Trading History

RVMDRevolution Medicines		Sep 18, 2026President & CEO, DirectorUninformative Sell2.79M$185.62M
CNSTConstellation Pharmaceuticals		Dec 28, 2020―Uninformative Sell140.74K$3.05M
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

MARK A GOLDSMITH insider profile FAQ

What is the percentage of profitable transactions made by MARK A GOLDSMITH?
The percentage of profitable transactions made by MARK A GOLDSMITH is 43%.
What is the average return per transaction made by MARK A GOLDSMITH?
The average return per transaction made by MARK A GOLDSMITH is -32.90%.
What stocks does MARK A GOLDSMITH hold?
MARK A GOLDSMITH holds: RVMD, CNST stocks.
What was MARK A GOLDSMITH’s latest transaction?
MARK A GOLDSMITH’s latest transaction was an Uninformative Sell of $2.79M.
What was MARK A GOLDSMITH's most profitable transaction?
MARK A GOLDSMITH’s most profitable transaction was an Informative Sell of RVMD stock on September 21, 2021. The return on the trade was 45.50%.
What is MARK A GOLDSMITH's role in Revolution Medicines?
MARK A GOLDSMITH's role in Revolution Medicines is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.